Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment. - Wikidata - awgldk - TriplyDB

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

http://www.wikidata.org/entity/Q33420446

about

Current management of heparin-induced thrombocytopenia.Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.Autoimmune heparin-induced thrombocytopenia.Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest.Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report

P2860

Q33425840-DF8662BB-B1F4-4351-8836-15C650B01631 Q33437546-212FAF1F-2865-436F-9EBD-3304777EC02B Q33440890-9E99FED2-0842-4B1A-8949-97CF4DF7A567 Q33441202-698DC53F-E8A4-48FA-8FAB-E227BAA3B56A Q38605630-015A8747-5764-4AFE-AF45-5337B48D3132 Q47654986-A5ACC0C7-78FD-4F26-9190-A62907309660 Q48102172-3D739EFB-EDA9-47C9-9F1A-9D3C34A2AC20 Q57824209-BE1D200B-1E6E-4911-A004-F76F7438E7C8 Q58739633-F11B518B-E1D9-4FC1-88F0-7BDC5DB96515

P2860

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

http://www.wikidata.org/entity/Q33420446

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@ast

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@en

type

label

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@ast

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@en

prefLabel

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@ast

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@en

P1433

Q33420446-D3EB83D2-0E4D-4179-946D-CEA921C7847F

P1476

Q33420446-F75D663B-9F49-451F-B6D0-EABBE1D31443

P2093

Q33420446-3D0EB534-C4AB-42E8-8A1D-BDE32D9A8C6C

Q33420446-4B81B91E-CCFB-4BE4-B5FA-31480A18A845

Q33420446-93455FEE-8F9A-464B-BF31-AA0FFE6B9049

Q33420446-C7FBB445-8623-4C06-A828-EC723D0CA718

P2860

Q33420446-0497D9CD-D358-499F-88D5-863FAC516F85

Q33420446-075AA7D0-B215-4FF1-867D-9163D6981536

Q33420446-53C57559-41DC-46CB-A519-7349E7C731A7

Q33420446-5C132E28-55B7-40F8-9522-2E7D077F81CE

Q33420446-664D8E52-1CA4-4A2E-88EA-670611A3D8F9

Q33420446-6E437F31-6BBB-48D1-BD9A-BA769983F0D5

Q33420446-72E0F35E-E700-424C-A85B-512DF3447061

Q33420446-795F7589-629E-4436-A911-6AD799580C88

Q33420446-7EA18F70-7441-454D-8E86-C67778433811

Q33420446-83041E22-A3EA-4005-AA74-CAD5689F0E90

P304

Q33420446-5800D171-2921-479B-8B2C-FD115754C54E

P31

Q33420446-2D4B86A2-B7D6-438C-BF13-1BC8803FF50F

P356

Q33420446-ED8A08C1-337C-44E0-BD00-543719B91E35

P433

Q33420446-3926D8E6-B592-423F-A317-6C1E95DDE12E

P478

Q33420446-755DAB18-668A-4947-8DA3-D5100230C089

P50

Q33420446-93482B5D-DB18-4E88-AF83-EF3685F95112

P577

Q33420446-4BFC78E6-6D0A-4713-9581-32E2997049A6

P698

Q33420446-44137991-EDB3-4DD5-ABEA-AA79B7551C63

P921

Q33420446-D9544C75-9463-445C-A0D8-1986D19EB35D

P356

P1433

American Journal of Hematology

P1476

Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

@en

P2093

Ariella Tvito

http://www.w3.org/2001/XMLSchema#string

Chezi Ganzel

http://www.w3.org/2001/XMLSchema#string

Jacob M Rowe

http://www.w3.org/2001/XMLSchema#string

Tamam Bakchoul

http://www.w3.org/2001/XMLSchema#string

P2860

The therapy of the heparin-induced thrombosis-thrombocytopenia syndrome with immunoglobulins

Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low-molecular-weight heparin.

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin.

Potential role of intravenous immunoglobulin in the management of peripartum maternal thrombocytopenia due to various causes.

A rare and undesirable complication of heparin-induced thrombocytopenia: acute massive pulmonary embolism.

Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.

Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.

P304

675-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23971

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Greinacher

P577

2015-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25683147

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia